| Opella Healthcare Switzerland AG - Telfastin 180, überzogene Tabletten | | 61283 | | 02 | | Telfastin 180 | | überzogene Tabletten | | R06AX26 | | Fexofenadin | | 24.08.2021 | | |
| | Composition | | fexofenadini hydrochloridum 180 mg, cellulosum microcristallinum, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 0.18 mg, magnesii stearas, Überzug: hypromellosum, polyvidonum K 29-32, E 171, silica colloidalis anhydrica, macrogolum 400, E 172 (rubrum), E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | überzogene Tabletten | | | | Principe actif | Concentr. |
|---|
| Fexofénadine Hydrochloride | 180 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polyvidonum K | 29-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 011 | 10 | DDP | DDP | D | | Non |
|
|
